HIV treatments in Africa: the importance of extended clinical trials in the field
The NAMSAL clinical trial, launched in 2016, continues to deliver pertinent results for the care provided to HIV patients in several countries in sub-Saharan Africa. This program has confirmed Dolutegravir’s position as the treatment of choice, while also observing undesirable side effects in some...